| 000 | 01638 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516224816.0 | ||
| 264 | 0 | _c20150416 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1744-8409 | ||
| 024 | 7 |
_a10.1586/1744666X.2014.944162 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBiermann, Mona H C | |
| 245 | 0 | 0 |
_aThe role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets. _h[electronic resource] |
| 260 |
_bExpert review of clinical immunology _cSep 2014 |
||
| 300 |
_a1151-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntigen Presentation |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aAutoantibodies _xmetabolism |
| 650 | 0 | 4 |
_aAutoantigens _ximmunology |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 |
_aDendritic Cells _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxychloroquine _xpharmacology |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
| 650 | 0 | 4 |
_aPhagocytosis _ximmunology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aToll-Like Receptors _xantagonists & inhibitors |
| 700 | 1 | _aVeissi, Susan | |
| 700 | 1 | _aMaueröder, Christian | |
| 700 | 1 | _aChaurio, Ricardo | |
| 700 | 1 | _aBerens, Christian | |
| 700 | 1 | _aHerrmann, Martin | |
| 700 | 1 | _aMunoz, Luis E | |
| 773 | 0 |
_tExpert review of clinical immunology _gvol. 10 _gno. 9 _gp. 1151-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/1744666X.2014.944162 _zAvailable from publisher's website |
| 999 |
_c24059871 _d24059871 |
||